Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
20
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Nussbaum Jared R. | 10% Owner | 6 | $0 | $0 | 2024-06-28 |
| Gil Eladio | Interim CFO | 2 | $0 | $0 | 2024-06-28 |
| Kent Mark D. | Interim CEO | 9 | $0 | $0 | 2024-06-28 |
| Camerlinck Robert | Chief Operating Officer | 11 | $0 | $23.6K | 2024-06-28 |
| Armstrong David J | See remarks | 20 | $150.3K | $4.4K | 2024-06-28 |
| Morales Angel L | Director | 8 | $0 | $0 | 2024-06-28 |
| Rivera Kim M | Director | 4 | $0 | $0 | 2024-06-28 |
| MUNEY ALAN | Director | 4 | $0 | $0 | 2024-06-28 |
| TRUJILLO SOLOMON D | Director | 9 | $1.02M | $0 | 2024-06-28 |
| Cooperstone Elliot | Director, 10% Owner | 22 | $0 | $2.01M | 2024-02-01 |
| ITC Rumba, LLC | 10% Owner | 15 | $0 | $1.97M | 2024-01-29 |
| Hernandez Marlow | Director | 60 | $20.36M | $0 | 2023-07-12 |
| Aguilar Richard | Chief Clinical Officer | 38 | $16.21M | $2.44M | 2023-06-29 |
| Guichelaar Jacqueline | Director | 3 | $0 | $0 | 2023-06-15 |
| Novell Mark | Chief Accounting Officer | 10 | $0 | $0 | 2023-05-31 |
| Koppy Brian D | Chief Financial Officer | 11 | $0 | $30.0K | 2023-05-31 |
| Gold Lewis | Director | 12 | $2.04M | $0 | 2022-05-16 |
| STERNLICHT BARRY S | Director, 10% Owner | 8 | $0 | $0 | 2022-05-16 |
| Jaws Sponsor LLC | 10% Owner | 5 | $0 | $0 | 2021-07-21 |
| Dowling Joseph L III | Chief Executive Officer | 1 | $0 | $0 | 2021-06-04 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Kent Mark D. | Interim CEO | A Award deriv | 2024-06-28 | 2024-07-02 | 94,416 | — | $0 | 94,416 | SEC↗ |
| Nussbaum Jared R. | 10% Owner | J Other deriv | 2024-06-28 | 2024-07-02 | 32,750 | — | $0 | 32,750 | SEC↗ |
| Nussbaum Jared R. | 10% Owner | J Other deriv | 2024-06-28 | 2024-07-02 | 347,603 | — | $0 | 347,603 | SEC↗ |
| Nussbaum Jared R. | 10% Owner | J Other deriv | 2024-06-28 | 2024-07-02 | 17,054 | — | $0 | 17,054 | SEC↗ |
| MUNEY ALAN | Director | D To issuer | 2024-06-28 | 2024-07-02 | 2,485 | — | $0 | 0 | SEC↗ |
| TRUJILLO SOLOMON D | Director | D To issuer | 2024-06-28 | 2024-07-02 | 3,782 | — | $0 | 0 | SEC↗ |
| TRUJILLO SOLOMON D | Director | D To issuer | 2024-06-28 | 2024-07-02 | 136,804 | — | $0 | 0 | SEC↗ |
| Morales Angel L | Director | D To issuer | 2024-06-28 | 2024-07-02 | 69,685 | — | $0 | 0 | SEC↗ |
| Morales Angel L | Director | D To issuer | 2024-06-28 | 2024-07-02 | 2,485 | — | $0 | 0 | SEC↗ |
| Camerlinck Robert | Chief Operating Officer | D To issuer | 2024-06-28 | 2024-07-02 | 269,586 | — | $0 | 0 | SEC↗ |
| Armstrong David J | See remarks | D To issuer | 2024-06-28 | 2024-07-02 | 6,641 | — | $0 | 0 | SEC↗ |
| Rivera Kim M | Director | D To issuer | 2024-06-28 | 2024-07-02 | 2,485 | — | $0 | 0 | SEC↗ |
| Kent Mark D. | Interim CEO | D To issuer | 2024-06-28 | 2024-07-02 | 15,296 | — | $0 | 0 | SEC↗ |
| Kent Mark D. | Interim CEO | D To issuer | 2024-06-28 | 2024-07-02 | 1,749 | — | $0 | 0 | SEC↗ |
| Kent Mark D. | Interim CEO | D To issuer | 2024-06-28 | 2024-07-02 | 23,609 | — | $0 | 0 | SEC↗ |
| Kent Mark D. | Interim CEO | D To issuer | 2024-06-28 | 2024-07-02 | 23,609 | — | $0 | 0 | SEC↗ |
| Kent Mark D. | Interim CEO | D To issuer | 2024-06-28 | 2024-07-02 | 45,995 | — | $0 | 0 | SEC↗ |
| Kent Mark D. | Interim CEO | D To issuer | 2024-06-28 | 2024-07-02 | 1,749 | — | $0 | 0 | SEC↗ |
| Gil Eladio | Interim CFO | D To issuer | 2024-06-28 | 2024-07-02 | 7,676 | — | $0 | 0 | SEC↗ |
| Nussbaum Jared R. | 10% Owner | J Other | 2024-06-28 | 2024-07-02 | 9,557,095 | — | $0 | 9,557,095 | SEC↗ |
| Nussbaum Jared R. | 10% Owner | J Other | 2024-06-28 | 2024-07-02 | 555,508 | — | $0 | 555,508 | SEC↗ |
| Nussbaum Jared R. | 10% Owner | J Other | 2024-06-28 | 2024-07-02 | 912,538 | — | $0 | 912,538 | SEC↗ |
| Cooperstone Elliot | 10% Owner | S Sale | 2024-02-01 | 2024-02-02 | 1,100 | $2.53 | $2.8K | 516,007 | SEC↗ |
| Cooperstone Elliot | 10% Owner | S Sale | 2024-01-31 | 2024-02-02 | 8,935 | $2.59 | $23.1K | 517,107 | SEC↗ |
| Cooperstone Elliot | 10% Owner | S Sale | 2024-01-30 | 2024-02-02 | 12,703 | $2.70 | $34.3K | 526,042 | SEC↗ |
| ITC Rumba, LLC | 10% Owner | S Sale | 2024-01-29 | 2024-01-29 | 41,357 | $2.74 | $113.3K | 538,745 | SEC↗ |
| ITC Rumba, LLC | 10% Owner | S Sale | 2024-01-26 | 2024-01-29 | 32,693 | $2.74 | $89.6K | 580,102 | SEC↗ |
| ITC Rumba, LLC | 10% Owner | S Sale | 2024-01-25 | 2024-01-29 | 18,569 | $2.58 | $47.9K | 612,795 | SEC↗ |
| ITC Rumba, LLC | 10% Owner | S Sale | 2024-01-24 | 2024-01-24 | 35,808 | $2.84 | $101.7K | 631,364 | SEC↗ |
| ITC Rumba, LLC | 10% Owner | S Sale | 2024-01-23 | 2024-01-24 | 73,034 | $2.94 | $214.7K | 667,172 | SEC↗ |
| ITC Rumba, LLC | 10% Owner | S Sale | 2024-01-22 | 2024-01-24 | 125,000 | $2.50 | $312.5K | 740,206 | SEC↗ |
| ITC Rumba, LLC | 10% Owner | S Sale | 2024-01-18 | 2024-01-19 | 100,000 | $1.91 | $191.0K | 865,206 | SEC↗ |
| ITC Rumba, LLC | 10% Owner | S Sale | 2024-01-17 | 2024-01-19 | 5,987 | $2.92 | $17.5K | 965,206 | SEC↗ |
| ITC Rumba, LLC | 10% Owner | S Sale | 2024-01-17 | 2024-01-19 | 94,013 | $2.28 | $214.3K | 971,193 | SEC↗ |
| Cooperstone Elliot | 10% Owner | C Conversion deriv | 2024-01-12 | 2024-01-12 | 1,065,206 | — | $0 | 0 | SEC↗ |
| Cooperstone Elliot | 10% Owner | C Conversion deriv | 2024-01-12 | 2024-01-12 | 1,065,206 | — | $0 | 1,065,206 | SEC↗ |
| Cooperstone Elliot | 10% Owner | S Sale | 2024-01-12 | 2024-01-12 | 24,171 | $3.30 | $79.8K | 0 | SEC↗ |
| Cooperstone Elliot | 10% Owner | C Conversion | 2024-01-12 | 2024-01-12 | 1,065,206 | — | $0 | 1,065,206 | SEC↗ |
| Cooperstone Elliot | 10% Owner | S Sale | 2024-01-11 | 2024-01-12 | 25,000 | $3.59 | $89.8K | 24,171 | SEC↗ |
| Cooperstone Elliot | 10% Owner | S Sale | 2024-01-10 | 2024-01-12 | 25,000 | $3.73 | $93.3K | 49,171 | SEC↗ |
| Cooperstone Elliot | 10% Owner | S Sale | 2024-01-09 | 2024-01-09 | 25,000 | $3.75 | $93.8K | 74,171 | SEC↗ |
| Cooperstone Elliot | 10% Owner | S Sale | 2024-01-08 | 2024-01-09 | 25,000 | $3.82 | $95.5K | 99,171 | SEC↗ |
| Cooperstone Elliot | 10% Owner | S Sale | 2024-01-05 | 2024-01-09 | 25,000 | $3.85 | $96.3K | 124,171 | SEC↗ |
| Cooperstone Elliot | 10% Owner | S Sale | 2024-01-04 | 2024-01-04 | 13,328 | $4.00 | $53.3K | 149,171 | SEC↗ |
| Cooperstone Elliot | 10% Owner | S Sale | 2024-01-03 | 2024-01-04 | 24,182 | $4.94 | $119.5K | 162,499 | SEC↗ |
| Cooperstone Elliot | 10% Owner | S Sale | 2024-01-03 | 2024-01-04 | 50,818 | $4.08 | $207.3K | 186,681 | SEC↗ |
| Cooperstone Elliot | 10% Owner | S Sale | 2024-01-02 | 2024-01-04 | 43,505 | $5.42 | $235.8K | 237,499 | SEC↗ |
| ITC Rumba, LLC | 10% Owner | S Sale | 2023-12-29 | 2023-12-29 | 35,112 | $6.00 | $210.7K | 281,004 | SEC↗ |
| ITC Rumba, LLC | 10% Owner | S Sale | 2023-12-28 | 2023-12-29 | 41,197 | $6.00 | $247.2K | 316,116 | SEC↗ |
| ITC Rumba, LLC | 10% Owner | S Sale | 2023-12-27 | 2023-12-29 | 37,607 | $5.65 | $212.5K | 357,313 | SEC↗ |
| Cooperstone Elliot | 10% Owner | S Sale | 2023-12-26 | 2023-12-26 | 21,154 | $5.44 | $115.1K | 394,920 | SEC↗ |
| Cooperstone Elliot | 10% Owner | S Sale | 2023-12-22 | 2023-12-26 | 27,377 | $5.65 | $154.7K | 416,074 | SEC↗ |
| Cooperstone Elliot | 10% Owner | S Sale | 2023-12-21 | 2023-12-26 | 82,843 | $5.67 | $469.7K | 449,760 | SEC↗ |
| Cooperstone Elliot | 10% Owner | S Sale | 2023-12-21 | 2023-12-26 | 6,309 | $6.62 | $41.8K | 443,451 | SEC↗ |
| ITC Rumba, LLC | 10% Owner | C Conversion deriv | 2023-12-15 | 2023-12-19 | 532,603 | — | $0 | 1,065,206 | SEC↗ |
| ITC Rumba, LLC | 10% Owner | C Conversion deriv | 2023-12-15 | 2023-12-19 | 532,603 | — | $0 | 1,065,206 | SEC↗ |
| ITC Rumba, LLC | 10% Owner | C Conversion | 2023-12-15 | 2023-12-19 | 532,603 | — | $0 | 532,603 | SEC↗ |
| TRUJILLO SOLOMON D | Director | C Conversion deriv | 2023-12-07 | 2023-12-08 | 136,804 | — | $0 | 0 | SEC↗ |
| TRUJILLO SOLOMON D | Director | C Conversion deriv | 2023-12-07 | 2023-12-08 | 136,804 | — | $0 | 0 | SEC↗ |
| TRUJILLO SOLOMON D | Director | C Conversion | 2023-12-07 | 2023-12-08 | 136,804 | — | $0 | 136,804 | SEC↗ |
| Morales Angel L | Director | C Conversion deriv | 2023-11-20 | 2023-11-22 | 69,685 | — | $0 | 0 | SEC↗ |
| Morales Angel L | Director | C Conversion deriv | 2023-11-20 | 2023-11-22 | 69,685 | — | $0 | 0 | SEC↗ |
| Morales Angel L | Director | C Conversion | 2023-11-20 | 2023-11-22 | 69,685 | — | $0 | 69,685 | SEC↗ |
| Gil Eladio | Interim CFO | A Award | 2023-11-10 | 2023-11-14 | 7,676 | — | $0 | 7,676 | SEC↗ |
| Camerlinck Robert | Chief Operating Officer | S Sale | 2023-08-11 | 2023-08-15 | 30,646 | $0.77 | $23.6K | 26,958,642 | SEC↗ |
| Hernandez Marlow | Director | A Award | 2023-07-12 | 2023-07-14 | 189,681 | — | $0 | 4,942,605 | SEC↗ |
| Kent Mark D. | Interim CEO | A Award | 2023-07-12 | 2023-07-14 | 216,237 | — | $0 | 391,606 | SEC↗ |
| Kent Mark D. | Interim CEO | A Award | 2023-07-12 | 2023-07-14 | 1,138,088 | — | $0 | 1,529,694 | SEC↗ |
| Armstrong David J | See remarks | A Award | 2023-06-30 | 2023-07-14 | 7,506 | $0.77 | $5.8K | 664,132 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | S Sale | 2023-06-29 | 2023-06-30 | 400,000 | $1.31 | $524.0K | 1,213,984 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | S Sale | 2023-06-28 | 2023-06-30 | 150,000 | $1.22 | $183.0K | 1,613,984 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | C Conversion deriv | 2023-06-26 | 2023-06-28 | 550,000 | — | $0 | 4,742,276 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | C Conversion deriv | 2023-06-26 | 2023-06-28 | 550,000 | — | $0 | 4,742,276 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | C Conversion | 2023-06-26 | 2023-06-28 | 550,000 | — | $0 | 1,763,984 | SEC↗ |
| Guichelaar Jacqueline | Director | A Award | 2023-06-15 | 2023-06-20 | 185,598 | — | $0 | 248,500 | SEC↗ |
| Morales Angel L | Director | A Award | 2023-06-15 | 2023-06-20 | 185,598 | — | $0 | 248,500 | SEC↗ |
| MUNEY ALAN | Director | A Award | 2023-06-15 | 2023-06-20 | 185,598 | — | $0 | 248,500 | SEC↗ |
| Rivera Kim M | Director | A Award | 2023-06-15 | 2023-06-20 | 185,598 | — | $0 | 248,500 | SEC↗ |
| TRUJILLO SOLOMON D | Director | A Award | 2023-06-15 | 2023-06-20 | 211,581 | — | $0 | 378,214 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | S Sale | 2023-06-12 | 2023-06-13 | 500,000 | $1.42 | $710.0K | 1,213,984 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | S Sale | 2023-06-09 | 2023-06-13 | 100,000 | $1.38 | $138.0K | 1,713,984 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | G Gift | 2023-06-08 | 2023-06-13 | 600,000 | — | $0 | 0 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | G Gift | 2023-06-08 | 2023-06-13 | 600,000 | — | $0 | 2,089,924 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | S Sale | 2023-06-08 | 2023-06-13 | 275,940 | $1.29 | $356.0K | 1,813,984 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | S Sale | 2023-06-07 | 2023-06-13 | 400,000 | $1.32 | $528.0K | 1,489,924 | SEC↗ |
| Armstrong David J | See remarks | S Sale | 2023-06-06 | 2023-06-07 | 3,163 | $1.38 | $4.4K | 656,626 | SEC↗ |
| Novell Mark | Chief Accounting Officer | A Award | 2023-05-31 | 2023-06-02 | 60,502 | — | $0 | 232,067 | SEC↗ |
| Hernandez Marlow | CEO | A Award | 2023-05-31 | 2023-06-02 | 671,742 | — | $0 | 4,701,256 | SEC↗ |
| Armstrong David J | See remarks | A Award | 2023-05-31 | 2023-06-02 | 109,526 | — | $0 | 659,789 | SEC↗ |
| Koppy Brian D | Chief Financial Officer | A Award | 2023-05-31 | 2023-06-02 | 248,226 | — | $0 | 1,050,796 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | A Award | 2023-05-31 | 2023-06-02 | 231,008 | — | $0 | 1,213,984 | SEC↗ |
| Camerlinck Robert | Chief Operating Officer | A Award | 2023-05-31 | 2023-06-02 | 239,139 | — | $0 | 26,989,288 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | C Conversion deriv | 2023-05-25 | 2023-06-13 | 600,000 | — | $0 | 5,292,276 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | C Conversion deriv | 2023-05-25 | 2023-06-13 | 675,940 | — | $0 | 0 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | C Conversion deriv | 2023-05-25 | 2023-06-13 | 675,940 | — | $0 | 0 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | C Conversion deriv | 2023-05-25 | 2023-06-13 | 600,000 | — | $0 | 5,292,276 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | C Conversion | 2023-05-25 | 2023-06-13 | 675,940 | — | $0 | 1,889,924 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | C Conversion | 2023-05-25 | 2023-06-13 | 600,000 | — | $0 | 600,000 | SEC↗ |
| Novell Mark | Chief Accounting Officer | A Award deriv | 2023-04-11 | 2023-04-13 | 32,131 | — | $0 | 32,131 | SEC↗ |
| Novell Mark | Chief Accounting Officer | A Award | 2023-04-11 | 2023-04-13 | 51,684 | — | $0 | 171,565 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | P Buy deriv | 2023-04-05 | 2023-04-06 | 4,991,807 | — | $0 | 4,991,807 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | S Sale deriv | 2023-04-05 | 2023-04-06 | 4,991,807 | — | $0 | 5,892,276 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | S Sale deriv | 2023-04-05 | 2023-04-06 | 4,991,807 | — | $0 | 5,892,276 | SEC↗ |
| Hernandez Marlow | CEO | S Sale deriv | 2023-04-05 | 2023-04-06 | 8,536,936 | — | $0 | 13,497,686 | SEC↗ |
| Hernandez Marlow | CEO | S Sale deriv | 2023-04-05 | 2023-04-06 | 8,536,936 | — | $0 | 13,497,686 | SEC↗ |
| Hernandez Marlow | CEO | P Buy deriv | 2023-04-05 | 2023-04-06 | 8,536,936 | — | $0 | 8,536,936 | SEC↗ |
| Camerlinck Robert | Chief Operating Officer | S Sale deriv | 2023-04-05 | 2023-04-10 | 20,000,000 | — | $0 | 0 | SEC↗ |
| Camerlinck Robert | Chief Operating Officer | J Other deriv | 2023-04-05 | 2023-04-10 | 17,163,460 | — | $0 | 17,163,460 | SEC↗ |
| Camerlinck Robert | Chief Operating Officer | J Other deriv | 2023-04-05 | 2023-04-10 | 17,163,460 | — | $0 | 17,163,460 | SEC↗ |
| Koppy Brian D | Chief Financial Officer | S Sale | 2023-04-05 | 2023-04-07 | 23,591 | $1.27 | $30.0K | 802,570 | SEC↗ |
| Camerlinck Robert | Chief Operating Officer | J Other | 2023-04-05 | 2023-04-10 | 2,836,540 | — | $0 | 26,750,149 | SEC↗ |
| Hernandez Marlow | CEO | A Award deriv | 2023-03-31 | 2023-04-04 | 729,730 | — | $0 | 729,730 | SEC↗ |
| Koppy Brian D | Chief Financial Officer | A Award deriv | 2023-03-31 | 2023-04-04 | 260,000 | — | $0 | 260,000 | SEC↗ |
| Camerlinck Robert | Chief Operating Officer | A Award deriv | 2023-03-31 | 2023-04-04 | 147,548 | — | $0 | 147,548 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | A Award deriv | 2023-03-31 | 2023-04-04 | 195,676 | — | $0 | 195,676 | SEC↗ |
| Armstrong David J | See remarks | A Award deriv | 2023-03-31 | 2023-04-04 | 146,757 | — | $0 | 146,757 | SEC↗ |
| Armstrong David J | See remarks | C Conversion deriv | 2023-03-31 | 2023-06-28 | 185,000 | — | $0 | 689,453 | SEC↗ |
| Armstrong David J | See remarks | C Conversion deriv | 2023-03-31 | 2023-06-28 | 185,000 | — | $0 | 689,453 | SEC↗ |
| Hernandez Marlow | CEO | A Award | 2023-03-31 | 2023-04-04 | 348,604 | — | $0 | 4,029,514 | SEC↗ |
| Koppy Brian D | Chief Financial Officer | A Award | 2023-03-31 | 2023-04-04 | 124,206 | — | $0 | 826,161 | SEC↗ |
| Camerlinck Robert | Chief Operating Officer | A Award | 2023-03-31 | 2023-04-04 | 70,486 | — | $0 | 23,913,609 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | A Award | 2023-03-31 | 2023-04-04 | 120,116 | — | $0 | 982,976 | SEC↗ |
| Armstrong David J | See remarks | A Award | 2023-03-31 | 2023-04-04 | 70,108 | — | $0 | 550,263 | SEC↗ |
| Armstrong David J | See remarks | C Conversion | 2023-03-31 | 2023-06-28 | 185,000 | — | $0 | 841,626 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | F Tax w/h | 2023-01-05 | 2023-01-09 | 27,010 | $1.08 | $29.2K | 862,860 | SEC↗ |
| Novell Mark | Chief Accounting Officer | F Tax w/h | 2023-01-05 | 2023-01-09 | 4,538 | $1.08 | $4.9K | 119,881 | SEC↗ |
| Armstrong David J | See remarks | F Tax w/h | 2023-01-05 | 2023-01-09 | 19,749 | $1.08 | $21.3K | 480,155 | SEC↗ |
| Koppy Brian D | Chief Financial Officer | F Tax w/h | 2023-01-05 | 2023-01-09 | 28,528 | $1.08 | $30.8K | 701,955 | SEC↗ |
| Hernandez Marlow | CEO | A Award | 2023-01-03 | 2023-01-05 | 134,660 | $0.87 | $117.2K | 3,680,910 | SEC↗ |
| Armstrong David J | See remarks | A Award | 2023-01-03 | 2023-01-05 | 13,006 | $0.87 | $11.3K | 499,904 | SEC↗ |
| Hernandez Marlow | CEO | J Other deriv | 2022-12-27 | 2022-12-29 | 11,017,311 | — | $0 | 22,034,622 | SEC↗ |
| Hernandez Marlow | CEO | J Other deriv | 2022-12-27 | 2022-12-29 | 11,017,311 | — | $0 | 22,034,622 | SEC↗ |
| Hernandez Marlow | CEO | J Other | 2022-12-27 | 2022-12-29 | 11,017,311 | — | $0 | 0 | SEC↗ |
| Camerlinck Robert | Chief Operating Officer | J Other | 2022-09-01 | 2022-09-06 | 25,386 | — | $0 | 23,843,123 | SEC↗ |
| Armstrong David J | See remarks | F Tax w/h | 2022-08-31 | 2022-09-02 | 20,500 | $5.95 | $122.0K | 486,898 | SEC↗ |
| Novell Mark | Chief Accounting Officer | F Tax w/h | 2022-08-31 | 2022-09-02 | 7,387 | $5.95 | $44.0K | 124,419 | SEC↗ |
| Koppy Brian D | Chief Financial Officer | F Tax w/h | 2022-08-31 | 2022-09-02 | 13,651 | $5.95 | $81.2K | 730,483 | SEC↗ |
| Novell Mark | Chief Accounting Officer | A Award | 2022-08-10 | 2022-08-12 | 24,000 | — | $0 | 131,806 | SEC↗ |
| Camerlinck Robert | Chief Operating Officer | A Award | 2022-08-10 | 2022-08-12 | 250,000 | — | $0 | 23,817,737 | SEC↗ |
| Armstrong David J | See remarks | A Award | 2022-07-05 | 2022-07-07 | 4,828 | $3.52 | $17.0K | 507,398 | SEC↗ |
| Hernandez Marlow | CEO | A Award | 2022-07-05 | 2022-07-07 | 29,870 | $3.52 | $105.1K | 3,546,250 | SEC↗ |
| Armstrong David J | See remarks | F Tax w/h | 2022-06-07 | 2022-06-08 | 3,254 | $5.14 | $16.7K | 502,570 | SEC↗ |
| Hernandez Marlow | CEO and President | C Conversion deriv | 2022-05-26 | 2022-05-31 | 11,017,311 | — | $0 | 11,017,311 | SEC↗ |
| Hernandez Marlow | CEO and President | C Conversion deriv | 2022-05-26 | 2022-05-31 | 11,017,311 | — | $0 | 11,017,311 | SEC↗ |
| Hernandez Marlow | CEO and President | C Conversion | 2022-05-26 | 2022-05-31 | 11,017,311 | — | $0 | 11,017,311 | SEC↗ |
| Rivera Kim M | Director | A Award | 2022-05-16 | 2022-05-18 | 48,077 | — | $0 | 62,902 | SEC↗ |
| Morales Angel L | Director | A Award | 2022-05-16 | 2022-05-18 | 48,077 | — | $0 | 62,902 | SEC↗ |
| Guichelaar Jacqueline | Director | A Award | 2022-05-16 | 2022-05-18 | 48,077 | — | $0 | 62,902 | SEC↗ |
| Cooperstone Elliot | Director, 10% Owner | A Award | 2022-05-16 | 2022-05-18 | 48,077 | — | $0 | 62,902 | SEC↗ |
| MUNEY ALAN | Director | A Award | 2022-05-16 | 2022-05-18 | 48,077 | — | $0 | 62,902 | SEC↗ |
| TRUJILLO SOLOMON D | Director | A Award | 2022-05-16 | 2022-05-18 | 54,808 | — | $0 | 166,633 | SEC↗ |
| Gold Lewis | Director | A Award | 2022-05-16 | 2022-05-18 | 48,077 | — | $0 | 362,902 | SEC↗ |
| STERNLICHT BARRY S | Director, 10% Owner | A Award | 2022-05-16 | 2022-05-18 | 48,077 | — | $0 | 12,854,233 | SEC↗ |
| Koppy Brian D | Chief Financial Officer | F Tax w/h | 2022-05-09 | 2022-05-12 | 40,484 | $4.38 | $177.3K | 744,134 | SEC↗ |
| Gold Lewis | Director | C Conversion deriv | 2022-03-21 | 2022-03-21 | 10,000 | — | $0 | 1,233,085 | SEC↗ |
| Gold Lewis | Director | C Conversion deriv | 2022-03-21 | 2022-03-21 | 10,000 | — | $0 | 1,233,085 | SEC↗ |
| Gold Lewis | Director | C Conversion | 2022-03-21 | 2022-03-21 | 10,000 | — | $0 | 1,233,085 | SEC↗ |
| Gold Lewis | Director | P Buy | 2022-03-17 | 2022-03-21 | 300,000 | $6.81 | $2.04M | 314,825 | SEC↗ |
| Novell Mark | Chief Accounting Officer | A Award deriv | 2022-03-15 | 2022-03-17 | 6,449 | — | $0 | 6,449 | SEC↗ |
| Koppy Brian D | Chief Financial Officer | A Award deriv | 2022-03-15 | 2022-03-17 | 36,681 | — | $0 | 36,681 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | A Award deriv | 2022-03-15 | 2022-03-17 | 37,320 | — | $0 | 37,320 | SEC↗ |
| Armstrong David J | See remarks | A Award deriv | 2022-03-15 | 2022-03-17 | 27,990 | — | $0 | 27,990 | SEC↗ |
| Hernandez Marlow | CEO | A Award deriv | 2022-03-15 | 2022-03-17 | 139,175 | — | $0 | 139,175 | SEC↗ |
| Novell Mark | Chief Accounting Officer | A Award | 2022-03-15 | 2022-03-17 | 28,783 | — | $0 | 57,806 | SEC↗ |
| Koppy Brian D | Chief Financial Officer | A Award | 2022-03-15 | 2022-03-17 | 181,280 | — | $0 | 784,618 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | A Award | 2022-03-15 | 2022-03-17 | 171,641 | — | $0 | 889,870 | SEC↗ |
| Armstrong David J | See remarks | A Award | 2022-03-15 | 2022-03-17 | 125,474 | — | $0 | 505,824 | SEC↗ |
| Hernandez Marlow | CEO | A Award | 2022-03-15 | 2022-03-17 | 624,418 | — | $0 | 3,516,380 | SEC↗ |
| Novell Mark | Chief Accounting Officer | A Award | 2022-03-15 | 2022-03-22 | 50,000 | — | $0 | 107,806 | SEC↗ |
| Gold Lewis | Director | C Conversion deriv | 2022-02-07 | 2022-02-09 | 158,850 | — | $0 | 158,850 | SEC↗ |
| Gold Lewis | Director | C Conversion deriv | 2022-02-07 | 2022-02-09 | 158,850 | — | $0 | 158,850 | SEC↗ |
| Gold Lewis | Director | C Conversion deriv | 2022-02-07 | 2022-02-09 | 1,223,085 | — | $0 | 1,223,085 | SEC↗ |
| Gold Lewis | Director | C Conversion deriv | 2022-02-07 | 2022-02-09 | 1,223,085 | — | $0 | 1,223,085 | SEC↗ |
| Gold Lewis | Director | C Conversion | 2022-02-07 | 2022-02-09 | 1,223,085 | — | $0 | 1,223,085 | SEC↗ |
| Gold Lewis | Director | C Conversion | 2022-02-07 | 2022-02-09 | 158,850 | — | $0 | 158,850 | SEC↗ |
| Cooperstone Elliot | Director, 10% Owner | A Award | 2022-01-28 | 2022-02-01 | 14,825 | — | $0 | 14,825 | SEC↗ |
| MUNEY ALAN | Director | A Award | 2022-01-28 | 2022-02-01 | 14,825 | — | $0 | 14,825 | SEC↗ |
| Gold Lewis | Director | A Award | 2022-01-28 | 2022-02-01 | 14,825 | — | $0 | 14,825 | SEC↗ |
| TRUJILLO SOLOMON D | Director | A Award | 2022-01-28 | 2022-02-01 | 14,825 | — | $0 | 111,825 | SEC↗ |
| STERNLICHT BARRY S | Director, 10% Owner | A Award | 2022-01-28 | 2022-02-01 | 14,825 | — | $0 | 14,825 | SEC↗ |
| Morales Angel L | Director | A Award | 2022-01-28 | 2022-02-01 | 14,825 | — | $0 | 14,825 | SEC↗ |
| Guichelaar Jacqueline | Director | A Award | 2022-01-28 | 2022-02-01 | 14,825 | — | $0 | 14,825 | SEC↗ |
| Rivera Kim M | Director | A Award | 2022-01-28 | 2022-02-01 | 14,825 | — | $0 | 14,825 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | A Award | 2022-01-18 | 2022-01-20 | 200,000 | — | $0 | 771,229 | SEC↗ |
| Armstrong David J | See remarks | A Award | 2022-01-18 | 2022-01-20 | 50,000 | — | $0 | 380,350 | SEC↗ |
| Koppy Brian D | Chief Financial Officer | A Award | 2022-01-13 | 2022-01-18 | 373,972 | — | $0 | 603,338 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | J Other | 2021-12-22 | 2021-12-22 | 119,407 | — | $0 | 529,895 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy deriv | 2021-12-06 | 2021-12-07 | 14,999 | $2.20 | $33.0K | 473,469 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy | 2021-12-06 | 2021-12-07 | 15,000 | $8.00 | $120.0K | 2,891,962 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy deriv | 2021-12-03 | 2021-12-06 | 22,001 | $2.38 | $52.4K | 458,470 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy | 2021-12-03 | 2021-12-06 | 12,500 | $8.75 | $109.4K | 2,876,962 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy deriv | 2021-12-01 | 2021-12-06 | 10,000 | $2.59 | $25.9K | 436,469 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy deriv | 2021-11-30 | 2021-12-01 | 15,000 | $2.39 | $35.9K | 426,469 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy deriv | 2021-11-23 | 2021-11-24 | 20,000 | $2.40 | $48.0K | 411,469 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy deriv | 2021-11-22 | 2021-11-24 | 10,000 | $2.60 | $26.0K | 391,469 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy | 2021-11-22 | 2021-11-24 | 8,000 | $9.65 | $77.2K | 2,864,462 | SEC↗ |
| TRUJILLO SOLOMON D | Director | P Buy | 2021-11-18 | 2021-11-30 | 97,000 | $10.55 | $1.02M | 97,000 | SEC↗ |
| Armstrong David J | See remarks | A Award | 2021-09-21 | 2021-09-24 | 285,333 | — | $0 | 300,333 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | A Award | 2021-09-21 | 2021-09-24 | 285,333 | — | $0 | 410,488 | SEC↗ |
| Koppy Brian D | Chief Financial Officer | A Award | 2021-09-21 | 2021-09-24 | 190,000 | — | $0 | 190,000 | SEC↗ |
| Hernandez Marlow | CEO and President | A Award | 2021-09-21 | 2021-09-24 | 1,339,500 | — | $0 | 2,856,462 | SEC↗ |
| Novell Mark | Chief Accounting Officer | A Award | 2021-09-21 | 2021-09-27 | 29,023 | — | $0 | 29,023 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy deriv | 2021-09-04 | 2021-09-08 | 70,000 | $10.75 | $752.5K | 70,000 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy deriv | 2021-09-04 | 2021-09-08 | 70,000 | $10.75 | $752.5K | 70,000 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy deriv | 2021-08-31 | 2021-09-02 | 40,419 | $3.77 | $152.4K | 46,987 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy deriv | 2021-08-31 | 2021-09-02 | 94,311 | $3.77 | $355.6K | 381,469 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy | 2021-08-31 | 2021-09-02 | 2,500 | $11.99 | $30.0K | 67,597 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy | 2021-08-31 | 2021-09-02 | 5,833 | $11.99 | $69.9K | 1,516,962 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | P Buy deriv | 2021-08-30 | 2021-08-31 | 651,163 | $10.75 | $7.00M | 651,163 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | P Buy deriv | 2021-08-30 | 2021-08-31 | 651,163 | $10.75 | $7.00M | 651,163 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | P Buy deriv | 2021-08-30 | 2021-09-14 | 24,777 | $10.75 | $266.4K | 675,940 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | P Buy deriv | 2021-08-30 | 2021-09-14 | 24,777 | $10.75 | $266.4K | 675,940 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy | 2021-08-30 | 2021-08-31 | 1,173,276 | $10.75 | $12.61M | 1,511,129 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy | 2021-08-30 | 2021-08-31 | 2,500 | $11.92 | $29.8K | 65,097 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy | 2021-08-30 | 2021-08-31 | 5,833 | $11.87 | $69.2K | 337,853 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | P Buy | 2021-08-30 | 2021-09-01 | 1,749 | $11.93 | $20.9K | 125,155 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy | 2021-08-27 | 2021-08-31 | 2,500 | $11.77 | $29.4K | 62,597 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy | 2021-08-27 | 2021-08-31 | 5,833 | $11.84 | $69.1K | 332,020 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | P Buy deriv | 2021-08-26 | 2021-08-31 | 38,589 | $3.81 | $147.0K | 46,710 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy deriv | 2021-08-26 | 2021-08-31 | 3,896 | $3.81 | $14.8K | 6,568 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy deriv | 2021-08-26 | 2021-08-31 | 9,091 | $3.81 | $34.6K | 287,158 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | P Buy | 2021-08-26 | 2021-08-31 | 72,013 | $11.99 | $863.4K | 123,406 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy | 2021-08-26 | 2021-08-31 | 6,240 | $11.62 | $72.5K | 60,097 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy | 2021-08-26 | 2021-08-31 | 14,560 | $11.79 | $171.7K | 326,187 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | P Buy deriv | 2021-08-25 | 2021-08-31 | 8,121 | $3.62 | $29.4K | 8,121 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy deriv | 2021-08-25 | 2021-08-31 | 2,672 | $3.62 | $9.7K | 2,672 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy deriv | 2021-08-25 | 2021-08-31 | 6,235 | $3.62 | $22.6K | 278,067 | SEC↗ |
| Aguilar Richard | Chief Clinical Officer | P Buy | 2021-08-25 | 2021-08-31 | 51,393 | $11.93 | $613.1K | 51,393 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy | 2021-08-25 | 2021-08-31 | 53,857 | $11.94 | $643.1K | 53,857 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy | 2021-08-25 | 2021-08-31 | 54,727 | $11.93 | $652.9K | 311,627 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy deriv | 2021-08-20 | 2021-08-23 | 5,000 | $2.75 | $13.8K | 271,832 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy | 2021-08-20 | 2021-08-23 | 10,000 | $10.20 | $102.0K | 256,900 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy deriv | 2021-08-19 | 2021-08-23 | 15,000 | $2.89 | $43.4K | 266,832 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy | 2021-08-19 | 2021-08-23 | 25,000 | $10.38 | $259.5K | 246,900 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy deriv | 2021-08-18 | 2021-08-23 | 1,832 | $2.30 | $4.2K | 251,832 | SEC↗ |
| Armstrong David J | See remarks | A Award | 2021-08-18 | 2021-08-19 | 15,000 | $10.02 | $150.3K | 15,000 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy | 2021-08-18 | 2021-08-23 | 11,900 | $9.82 | $116.9K | 221,900 | SEC↗ |
| Armstrong David J | See remarks | P Buy | 2021-08-18 | 2021-08-24 | 15,000 | $10.02 | $150.3K | 15,000 | SEC↗ |
| Hernandez Marlow | CEO and President | A Award deriv | 2021-08-17 | 2021-08-18 | 90,000 | $2.51 | $225.9K | 250,000 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy deriv | 2021-08-17 | 2021-08-23 | 90,000 | $2.51 | $225.9K | 250,000 | SEC↗ |
| Hernandez Marlow | CEO and President | A Award | 2021-08-17 | 2021-08-18 | 90,000 | $9.55 | $859.5K | 210,000 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy | 2021-08-17 | 2021-08-23 | 90,000 | $9.55 | $859.5K | 210,000 | SEC↗ |
| Hernandez Marlow | CEO and President | A Award deriv | 2021-08-16 | 2021-08-18 | 160,000 | $2.77 | $443.2K | 160,000 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy deriv | 2021-08-16 | 2021-08-23 | 160,000 | $2.77 | $443.2K | 160,000 | SEC↗ |
| Hernandez Marlow | CEO and President | A Award | 2021-08-16 | 2021-08-18 | 120,000 | $10.16 | $1.22M | 120,000 | SEC↗ |
| Hernandez Marlow | CEO and President | P Buy | 2021-08-16 | 2021-08-23 | 120,000 | $10.16 | $1.22M | 120,000 | SEC↗ |
| STERNLICHT BARRY S | Director, 10% Owner | J Other deriv | 2021-07-21 | 2021-07-23 | 2,688,694 | — | $0 | 7,844,639 | SEC↗ |
| Jaws Sponsor LLC | 10% Owner | J Other deriv | 2021-07-21 | 2021-07-23 | 10,533,333 | — | $0 | 0 | SEC↗ |
| STERNLICHT BARRY S | Director, 10% Owner | J Other | 2021-07-21 | 2021-07-23 | 4,383,669 | — | $0 | 34,831,848 | SEC↗ |
| Jaws Sponsor LLC | 10% Owner | J Other | 2021-07-21 | 2021-07-23 | 17,175,000 | — | $0 | 0 | SEC↗ |
| STERNLICHT BARRY S | Director, 10% Owner | J Other deriv | 2021-06-04 | 2021-06-07 | 17,175,000 | — | $0 | 0 | SEC↗ |
| STERNLICHT BARRY S | Director, 10% Owner | J Other deriv | 2021-06-04 | 2021-06-07 | 10,533,333 | $1.50 | $15.80M | 10,533,333 | SEC↗ |
| Jaws Sponsor LLC | 10% Owner | J Other deriv | 2021-06-04 | 2021-06-07 | 10,533,333 | $1.50 | $15.80M | 10,533,333 | SEC↗ |
| Jaws Sponsor LLC | 10% Owner | J Other deriv | 2021-06-04 | 2021-06-07 | 17,175,000 | — | $0 | 0 | SEC↗ |
| STERNLICHT BARRY S | Director, 10% Owner | J Other | 2021-06-04 | 2021-06-07 | 17,175,000 | — | $0 | 17,175,000 | SEC↗ |
| STERNLICHT BARRY S | Director, 10% Owner | A Award | 2021-06-04 | 2021-06-07 | 4,865,517 | $10.00 | $48.66M | 22,040,517 | SEC↗ |
| Jaws Sponsor LLC | 10% Owner | J Other | 2021-06-04 | 2021-06-07 | 17,175,000 | — | $0 | 17,175,000 | SEC↗ |
| Dowling Joseph L III | Chief Executive Officer | A Award | 2021-06-04 | 2021-06-07 | 52,500 | $10.00 | $525.0K | 52,500 | SEC↗ |